Sanofi Consumer Healthcare India Limited — Board Meeting, 02-05-2025: Outcome of Board Meeting

Sanofi Consumer Healthcare India has announced a board meeting on which the financial results for the quarter and half-year were approved. Revenue was ₹172.6 Cr with a profit after tax of ₹50 Cr for the quarter ended March 31, 2025, reflecting quarter-on-quarter improvement. The company is gradually recovering from last year’s product recall, relaunching Depura Adult and preparing to bring back other key products soon. Globally, Sanofi sold a 50% controlling stake in Opella to CD&R while retaining 48.2% ownership, signaling strategic portfolio adjustments.